Cargando…
Palmitoylethanolamide counteracts high-fat diet-induced gut dysfunction by reprogramming microbiota composition and affecting tryptophan metabolism
Obesity is associated with gastrointestinal (GI) tract and central nervous system (CNS) disorders. High-fat diet (HFD) feeding-induced obesity in mice induces dysbiosis, causing a shift toward bacteria-derived metabolites with detrimental effects on metabolism and inflammation: events often contribu...
Autores principales: | Pirozzi, Claudio, Coretti, Lorena, Opallo, Nicola, Bove, Maria, Annunziata, Chiara, Comella, Federica, Turco, Luigia, Lama, Adriano, Trabace, Luigia, Meli, Rosaria, Lembo, Francesca, Mattace Raso, Giuseppina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434518/ https://www.ncbi.nlm.nih.gov/pubmed/37599675 http://dx.doi.org/10.3389/fnut.2023.1143004 |
Ejemplares similares
-
Palmitoylethanolamide dampens neuroinflammation and anxiety-like behavior in obese mice
por: Lama, Adriano, et al.
Publicado: (2022) -
Zooming into Gut Dysbiosis in Parkinson’s Disease: New Insights from Functional Mapping
por: Turco, Luigia, et al.
Publicado: (2023) -
Palmitoylethanolamide Promotes White-to-Beige Conversion and Metabolic Reprogramming of Adipocytes: Contribution of PPAR-α
por: Annunziata, Chiara, et al.
Publicado: (2022) -
Dual-Hit Model of Parkinson’s Disease: Impact of Dysbiosis on 6-Hydroxydopamine-Insulted Mice—Neuroprotective and Anti-Inflammatory Effects of Butyrate
por: Avagliano, Carmen, et al.
Publicado: (2022) -
N-(1-carbamoyl-2-phenylethyl) butyramide reduces antibiotic-induced intestinal injury, innate immune activation and modulates microbiota composition
por: Lama, Adriano, et al.
Publicado: (2019)